Chimeric antigen receptors targeting B-cell maturation antigen Grant US-11912776-B2 United States of America 27 Feb 2024
Reducing junction epitope presentation for neoantigens Grant US-11885815-B2 United States of America 30 Jan 2024
Chimeric antigen receptors against multiple HLA-G isoforms Grant US-11505608-B2 United States of America 22 Nov 2022
Chimeric antigen receptors against multiple HLA-G isoforms Grant US-11325977-B2 United States of America 10 May 2022
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-11312782-B2 United States of America 26 Apr 2022
Neoantigen identification, manufacture, and use Grant US-11183286-B2 United States of America 23 Nov 2021
Chimeric antigen receptors against multiple HLA-G isoforms Grant US-11117971-B2 United States of America 14 Sep 2021
GENETICALLY ENGINEERED T CELL AND APPLICATION THEREOF Application EP-3680338-A4 European Patent Office 02 Jun 2021
Neoantigen identification, manufacture, and use Grant US-10847252-B2 United States of America 24 Nov 2020
Neoantigen identification, manufacture, and use Grant US-10847253-B2 United States of America 24 Nov 2020
SUICIDE MODULE COMPOSITIONS AND METHODS Application WO-2020072390-A1 World Intellectual Property Organisation (WIPO) 09 Apr 2020
CHIMERIC ANTIGEN RECEPTORS AGAINST MULTIPLE HLA-G ISOFORMS Application WO-2020043899-A1 World Intellectual Property Organisation (WIPO) 05 Mar 2020
CD19CART CELLS ELIMINATE MYELOMA CELLS THAT EXPRESS VERY LOW LEVELS OF CD19 Application WO-2019097082-A1 World Intellectual Property Organisation (WIPO) 23 May 2019